These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1889627)

  • 1. Chirality and its importance in drug development: a synthetic chemist's perspective.
    Roberts SM
    Biochem Soc Trans; 1991 Apr; 19(2):446-53. PubMed ID: 1889627
    [No Abstract]   [Full Text] [Related]  

  • 2. Chirality and its importance in drug development: an analytical chemist's perspective.
    Fell AF; Ley GW
    Biochem Soc Trans; 1991 Apr; 19(2):454-6. PubMed ID: 1889628
    [No Abstract]   [Full Text] [Related]  

  • 3. Chirality and its importance in drug development: what are the issues?
    Beckett AH
    Biochem Soc Trans; 1991 Apr; 19(2):443-6. PubMed ID: 1889626
    [No Abstract]   [Full Text] [Related]  

  • 4. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates.
    Roughley SD; Jordan AM
    J Med Chem; 2011 May; 54(10):3451-79. PubMed ID: 21504168
    [No Abstract]   [Full Text] [Related]  

  • 6. A medicinal chemist's guide to molecular interactions.
    Bissantz C; Kuhn B; Stahl M
    J Med Chem; 2010 Jul; 53(14):5061-84. PubMed ID: 20345171
    [No Abstract]   [Full Text] [Related]  

  • 7. Chirality and its importance in drug development.
    Campbell DB; Wilson K
    Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635
    [No Abstract]   [Full Text] [Related]  

  • 8. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic approaches to the 2007 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Li J
    Mini Rev Med Chem; 2008 Dec; 8(14):1526-48. PubMed ID: 19075810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainable Practices in Medicinal Chemistry Part 2: Green by Design.
    Aliagas I; Berger R; Goldberg K; Nishimura RT; Reilly J; Richardson P; Richter D; Sherer EC; Sparling BA; Bryan MC
    J Med Chem; 2017 Jul; 60(14):5955-5968. PubMed ID: 28375009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic approaches to the 2010 new drugs.
    Liu KK; Sakya SM; O'Donnell CJ; Flick AC; Ding HX
    Bioorg Med Chem; 2012 Feb; 20(3):1155-74. PubMed ID: 22261026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 13. Overview of the perspectives devoted to tautomerism in molecular design.
    Martin YC
    J Comput Aided Mol Des; 2010 Jun; 24(6-7):473-4. PubMed ID: 20428926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative fluorine-addition process could enable faster drug design and manufacture.
    Future Med Chem; 2009 Sep; 1(6):1028. PubMed ID: 21545053
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical synthesis of pharmaceutically relevant molecules enriched in sp
    Campbell PS; Jamieson C; Simpson I; Watson AJB
    Chem Commun (Camb); 2017 Dec; 54(1):46-49. PubMed ID: 29189836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Route design, the foundation of successful chemical development.
    Cornwall P; Diorazio LJ; Monks N
    Bioorg Med Chem; 2018 Aug; 26(14):4336-4347. PubMed ID: 29925485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic approaches to the 2013 new drugs.
    Ding HX; Leverett CA; Kyne RE; Liu KK; Fink SJ; Flick AC; O'Donnell CJ
    Bioorg Med Chem; 2015 May; 23(9):1895-922. PubMed ID: 25797159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical library synthesis using convergent approaches.
    Beeler AB; Schaus SE; Porco JA
    Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.